MiRNAs are being explored as therapeutic targets in cancer treatment. Strategies include miRNA replacement therapy, where tumor-suppressive miRNAs are reintroduced into cancer cells, and miRNA inhibition, where oncogenic miRNAs are blocked using anti-miRNA oligonucleotides. For instance, the inhibition of miR-221/222 has been shown to suppress tumor growth in glioblastoma.
